![]() Reimbursement will be based on incurred date of service.Reimbursement will be based on current year Medicare fee schedule rates except where otherwise noted.Claims reimbursementĬlaims for reimbursement will be priced as described below for eligible services (see coverage details above). Outpatient prescription drugs, except for the dispensing fee for FDA-licensed or authorized outpatient antiviral drugs for treatment of COVID-19.Īll claims submitted must be complete and final.Any treatment without a COVID-19 primary diagnosis, except for pregnancy when the COVID-19 code may be listed as secondary.In addition, the following services are excluded: Services not covered by traditional Medicare will also not be covered under this program. Administration fees related to FDA-licensed or authorized vaccines.Ĭlaims will be subject to Medicare timely filing requirements.Dispensing fees for FDA-licensed or authorized outpatient antiviral drugs for treatment of COVID-19.Treatment: office visit (including telehealth), emergency room, inpatient, outpatient/observation, skilled nursing facility, long-term acute care (LTAC), rehabilitation care, home health, durable medical equipment (e.g., oxygen, ventilator), emergency ambulance transportation, non-emergent patient transfers via ambulance, and FDA-licensed, authorized, or approved treatments as they become available for COVID-19 treatment.Testing-related visits including in the following settings: office, urgent care or emergency room or telehealth.Specimen collection, diagnostic and antibody testing.Reimbursement under this program will be made for qualifying testing for COVID-19, for treatment services with a primary COVID-19 diagnosis, and for qualifying COVID-19 vaccine administration fees, as determined by HRSA (subject to adjustment as may be necessary), which include the following: ![]() You agree to program terms and conditions (PDF - 123 KB) and may be subject to post-reimbursement audit review.You agree not to balance bill the patient.You will accept defined program reimbursement as payment in full.You have verified that the patient does not have coverage through an individual, or employer-sponsored plan, a federal healthcare program, or the Federal Employees Health Benefits Program at the time services were rendered, and no other payer will reimburse you for COVID-19 vaccination, testing and/or care for that patient. You have checked for health care coverage eligibility and confirmed that the patient is uninsured.To participate, providers must attest to the following at registration: Steps will involve: enrolling as a provider participant, checking patient eligibility, submitting patient information, submitting claims, and receiving payment via direct deposit. Providers can also request reimbursement for COVID-19 vaccine administration. Health care providers who have conducted COVID-19 testing or provided treatment for uninsured individuals with a COVID-19 primary diagnosis on or after February 4, 2020, can request claims reimbursement through the program electronically and will be reimbursed generally at Medicare rates, subject to available funding. Department of Health and Human Services (HHS), provides claims reimbursement to health care providers generally at Medicare rates for testing uninsured individuals for COVID-19, treating uninsured individuals with a COVID-19 diagnosis, and administering COVID-19 vaccines to uninsured individuals.Ī separate program, the HRSA COVID-19 Coverage Assistance Fund, is available to reimburse providers for COVID-19 vaccine administration to underinsured individuals whose health plan either does not include COVID-19 vaccination as a covered benefit or covers COVID-19 vaccine administration but with cost-sharing. View the list of providers who have received a reimbursement from the HRSA COVID-19 Uninsured Program. Requirements for COVID-19 Vaccination Program Providers – CDC guidance for providers administering COVID-19 vaccines.– find vaccines, tests, treatments, and masks, as well as the latest COVID-19 updates.COVID-19 Uninsured Program Claims Submission Deadline FAQs.*Submitted claims will be paid subject to the availability of funds. HRSA anticipates that claims submitted by the deadline may take longer than the typical 30 business day timeframe to process as HRSA works to adjudicate and pay claims subject to their eligibility. ET for vaccine administration will be processed for adjudication/payment. No claims submitted after April 5, 2022, at 11:59 p.m. ET for testing or treatment will be processed for adjudication/payment. No claims submitted after March 22, 2022, at 11:59 p.m. ![]() Confirmation of receipt of your claim submission does not mean the claim will be paid. The Uninsured Program stopped accepting claims due to a lack of sufficient funds.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |